Lumos Diagnostics Holdings Limited
LDXHF
$0.16
$0.00-0.93%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -2.95% | -2.95% | -27.15% | -27.15% | 127.98% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -2.95% | -2.95% | -27.15% | -27.15% | 127.98% |
| Cost of Revenue | -4.84% | -4.84% | -20.18% | -20.18% | 66.29% |
| Gross Profit | -2.03% | -2.03% | -31.75% | -31.75% | 178.33% |
| SG&A Expenses | 45.43% | 45.43% | 19.73% | 19.73% | 8.47% |
| Depreciation & Amortization | -5.36% | -5.36% | -12.62% | -12.62% | 3.86% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 29.22% | 29.22% | 2.92% | 2.92% | 16.41% |
| Operating Income | -87.72% | -87.72% | -126.99% | -126.99% | 38.40% |
| Income Before Tax | -74.04% | -74.04% | -100.96% | -100.96% | 56.28% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -74.04% | -74.04% | -100.96% | -100.96% | 56.28% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -74.04% | -74.04% | -100.96% | -100.96% | 56.28% |
| EBIT | -87.72% | -87.72% | -126.99% | -126.99% | 38.40% |
| EBITDA | -146.61% | -146.61% | -155.13% | -188.94% | 51.01% |
| EPS Basic | -39.13% | -39.13% | -26.09% | -26.09% | 68.06% |
| Normalized Basic EPS | -42.86% | -42.86% | -28.57% | -28.57% | 68.89% |
| EPS Diluted | -39.13% | -39.13% | -26.09% | -26.09% | 68.06% |
| Normalized Diluted EPS | -42.86% | -42.86% | -28.57% | -28.57% | 68.89% |
| Average Basic Shares Outstanding | 26.02% | 26.02% | 55.08% | 55.08% | 37.92% |
| Average Diluted Shares Outstanding | 26.02% | 26.02% | 55.08% | 55.08% | 37.92% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |